Search results
Abbott (ABT) Gets FDA Clearance for FreeStyle Libre 3 Reader
Zacks via Yahoo Finance· 1 year agoAbbott Laboratories ABT recently announced the FDA clearance of a standalone reader for its...
Dexcom vs. FreeStyle Libre: What to Know About These CGMs
Verywell Health via Yahoo News· 2 months agoDexcom and FreeStyle Libre are continuous glucose monitors that track blood sugar readings in real...
Tandem Diabetes (TNDM) and Abbott Debut New Integrated Offering
Zacks via Yahoo Finance· 5 months agoTandem Diabetes Care, Inc.’s TNDM flagship offering, t:slim X2 insulin pump, has recently become the...
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
Investor's Business Daily· 1 year agoDexcom stock toppled Monday after the Food and Drug Administration cleared Abbott Laboratories to...
Abbott CEO talks diabetes market, device pricing at J.P. Morgan conference
MedTech Dive via Yahoo Finance· 5 months agoAbbott CEO Robert Ford expects the company to meet its goal of $10 billion in sales for its Libre...
Dexcom, A Top 3% Stock, Nears A Breakout On A 'Landmark' Medicare Win
Investor's Business Daily· 1 year agoDexcom stock closed in on a breakout Monday after Medicare officials announced the biggest-ever...
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
Zacks via Yahoo Finance· 1 year agoTandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by the...
The Zacks Analyst Blog Highlights JPMorgan Chase, AbbVie, Abbott Laboratories, Intuit and...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – August 19, 2022 – Zacks.com announces the list of stocks...
These Glucose Meters and Monitors Make Diabetes Management a Bit Simpler
Good Housekeeping via AOL· 9 months ago9 Glucometers for Simpler Diabetes Managementvitapix - Getty Images The best glucose meter can make...
Q3 Earnings Scorecard and Analyst Reports for Apple, Abbott, IBM & Others
Zacks via Yahoo Finance· 2 years agoMonday, October 17, 2022 The Zacks Research Daily presents the best research output of our analyst...